Candel Therapeutics Inc. said its President and CEO Paul Peter Tak will present at TD Cowen’s 46th Annual Health Care Conference in Boston on March 3, 2026 (11:50 a.m.–12:20 p.m. ET). Webcast: https://www.globenewswire.com/Tracker?data=Ee3iUiZFpG1X7zJTz3Vt8i9KHxY_lE8SwIR1149FDYGM8au3A1Qc_KkjFQLlh0J_BANeXfy3jJ6ADUKm-dPMZTJmILLFLHN21apdkkPsEh-akBqWa9CB8LUTVoUUwcwf8hVd4N0Y1tS5UPTv2E3anW_pmksLT0P0djkLIpH4sp1_kFcdv4ckgVfWe5OHnP6k and https://www.globenewswire.com/Tracker?data=Ee3iUiZFpG1X7zJTz3Vt8i9KHxY_lE8SwIR1149FDYGM8au3A1Qc_KkjFQLlh0J_BANeXfy3jJ6ADUKm-dPMZTJmILLFLHN21apdkkPsEh-akBqWa9CB8LUTVoUUwcwf8hVd4N0Y1tS5UPTv2E3anW_pmksLT0P0djkLIpH4sp1_kFcdv4ckgVfWe5OHnP6k; investor-site access: https://www.candeltx.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240805PRIMZONEFULLFEED9659632) on February 24, 2026, and is solely responsible for the information contained therein.
Comments